New Generalized Epilepsy Data Have Been Reported by Investigators at Sapienza University of Rome (Topiramate Ban In Women of Childbearing Potential With Idiopathic Generalized Epilepsy: Does Effectiveness Offset the Teratogenic Risks?).

Předmět:	EPILEPSY CENTRAL nervous system diseases TOPIRAMATE
Zdroj:	Pain & Central Nervous System Week; 2024, p1966-1966, 1p
Abstrakt:	A recent study conducted at Sapienza University of Rome investigated the effectiveness of topiramate (TPM) and levetiracetam (LEV) as first-line antiseizure medication in women of childbearing potential with idiopathic generalized epilepsy (IGE). The study found that women treated with TPM had higher risks of treatment failure and withdrawal, and were less likely to achieve seizure freedom at 12 months compared to women treated with LEV. The study suggests that there is a low tendency among clinicians to use TPM in this population, and the available data on effectiveness do not support its use. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu